| Autor: |
Jaiswal, Aayushi, Srivarshini, Mudumba, Reddy, Patlolla Akshitha, Sundari, Tripura, Sunkavalli, Sirisha, Vandanasetti, Ramya, Begum, Shaheen, S. K., Arifa Begum |
| Předmět: |
|
| Zdroj: |
International Journal of Pharmaceutical Investigation; Jan-Mar2024, Vol. 14 Issue 1, p186-190, 5p |
| Abstrakt: |
Background: The Levonorgestrel-releasing intrauterine system was inserted in patients with conditions like Abnormal Uterine Bleeding (AUB), adenomyosis and Perimenopausal Bleeding (PMB). This study aimed to find the effectiveness and safety of the intrauterine device in AUB, adenomyosis and PMB. Materials and Methods: This observational study enrolled 100 patients with AUB, adenomyosis and PMB who had levonorgestrel IUD inserted for treatment between the years 2015 to 2022. The data has been collected from the Department of Obstetrics and Gynecology at Krishna Institute of Medical Sciences, Secunderabad and analyzed based on the Institutional outcome scoring form. The post-insertion responses, expulsion rates and clinical outcomes towards IUD were observed in patients after insertion. Results: The analysis of post-insertion responses showed a significant statistical P value of 0.001 which implies the effectiveness of IUD. This study resulted in a 90% positive clinical outcome which implies the safety of levonorgestrel IUD. The expulsion rate was also very low that was 5 out of 100 patients had the device expelled. Conclusion: The levonorgestrel IUD showed significant positive clinical outcomes in patients with AUB, Adenomyosis and PMB with low expulsion rates and can be considered a good alternative for conservative management of AUB, Adenomyosis, and perimenopausal bleeding. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
